Peptides for Women: GHK-Cu, Glutathione & NAD+ Research Guide

While peptides work through biological mechanisms shared by all humans, certain research applications are of particular interest to women's health investigators. Skin ageing, hormonal changes during perimenopause and menopause, oxidative stress, and bone density are areas where specific peptides show promising research data.

This guide focuses on the peptide compounds most frequently studied in the context of women's health, summarising published evidence and noting where data is strong versus preliminary.

All Peptides Pharma products are sold for research purposes only. This guide presents published research data and does not constitute medical advice. Women with specific health concerns should consult qualified healthcare professionals.

GHK-Cu is arguably the most relevant peptide for women's anti-ageing research, with direct clinical evidence for skin benefits:

Skin rejuvenation evidence: - Controlled clinical trials of topical GHK-Cu demonstrated measurable improvements in skin firmness (+35-40%), elasticity, and wrinkle depth after 8-12 weeks - Collagen Type I and III synthesis stimulation — these are the primary structural proteins that decline with age and accelerate during hormonal transitions - Elastin production support — maintaining skin elasticity

Relevance to women's ageing: Women experience accelerated collagen loss during perimenopause and menopause due to declining oestrogen. Research suggests collagen production drops approximately 30% in the first 5 years post-menopause. GHK-Cu's collagen-stimulating properties are therefore particularly relevant during this period.

Hair research: GHK-Cu has been studied for hair follicle health, with findings showing increased follicle size, enhanced growth cycle progression, and improved hair thickness in preclinical models. Female pattern hair thinning is a growing area of research interest.

Gene expression: GHK-Cu's modulation of 4,000+ genes includes pathways relevant to skin ageing, wound healing, and anti-inflammation — offering broad biological support.

Peptides Pharma's GHK-Cu Research Vial (€139) provides a 30-day supply in a pre-mixed injectable format.

Glutathione is the body's master antioxidant, and its decline with age has particular relevance to women's health research:

Skin brightening: Multiple clinical studies have demonstrated glutathione's effects on skin tone. Research shows glutathione reduces melanin synthesis (via tyrosinase inhibition), resulting in measurable skin brightening. This is one of the few peptide applications with direct cosmetic clinical trial data.

Antioxidant defence: Women's oxidative stress patterns differ from men's due to hormonal influences. During menstrual cycles, pregnancy, and menopause, oxidative stress fluctuates. Glutathione's role as the primary endogenous antioxidant makes it relevant to research across all these phases.

Immune support: Glutathione is essential for lymphocyte proliferation and natural killer cell activity. Women's immune systems differ functionally from men's (generally more robust adaptive immunity but higher autoimmune susceptibility), making glutathione's immune-modulating research particularly relevant.

Detoxification support: Glutathione is critical for Phase II liver detoxification — conjugating and neutralising toxins, medications, and environmental chemicals. Women metabolise many substances differently than men, making detoxification research important.

Why injectable? Oral glutathione has <5% bioavailability. Peptides Pharma's Glutathione Research Vial (€99) delivers the active tripeptide at near-100% bioavailability — the most cost-effective glutathione format for research applications.

NAD+ decline is implicated in many age-related changes that disproportionately affect women's health research areas:

Metabolic health: NAD+ is central to metabolic function. As levels decline, research associates this with reduced metabolic rate, insulin sensitivity changes, and altered body composition. Women's metabolic research often focuses on these transitions, particularly during perimenopause when metabolic rate typically decreases.

Cognitive function: NAD+ supports neuronal health through sirtuin activation and PARP-mediated DNA repair. Women face higher lifetime risk of cognitive decline, making NAD+'s neuroprotective research particularly relevant.

Bone health: Emerging research links NAD+ to osteoblast (bone-building cell) function. Given that women face significantly higher osteoporosis risk than men — particularly post-menopause — this research area is noteworthy.

Energy and fatigue: NAD+'s role in mitochondrial function (cellular energy production) makes it relevant to fatigue research. Chronic fatigue disproportionately affects women, and mitochondrial dysfunction is increasingly studied as a contributing factor.

Peptides Pharma offers two NAD+ formats: - NAD+ Research Vial (€189): 30-day supply, standard vial system - NAD+ Vial (€299): Advanced cartridge-based system for precision microdosing

While BPC-157 is often associated with athletic injury recovery, several research applications are particularly relevant to women:

Gut health: BPC-157 is derived from human gastric juice protein and has extensive research in gut healing models. Women experience digestive issues at higher rates than men (IBS affects women 2-3x more frequently). BPC-157's gastric protective and gut healing properties are therefore relevant to women's digestive health research.

Post-surgical recovery: Women undergo certain surgical procedures (caesarean sections, gynaecological surgeries) that BPC-157's tissue repair mechanisms may be relevant to study. Published data shows accelerated healing across multiple tissue types.

Joint health: Women are at higher risk for certain joint conditions, including ACL tears (2-8x higher than men in sports) and osteoarthritis. BPC-157's tendon and ligament healing research is relevant to these gender-specific injury patterns.

Peptides Pharma BPC-157 Research Vial: €119, 30-day supply

Popular women's health research combinations: - GHK-Cu + Glutathione (€238): Skin and antioxidant focus - NAD+ + Glutathione (€288-€398): Cellular energy and antioxidant defence - BPC-157 + GHK-Cu (€258): Recovery and skin research